{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:55Z","timestamp":1791999175208,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.08.046","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:38:18Z","timestamp":1282466298000},"page":"583-592","source":"Crossref","is-referenced-by-count":59,"title":["Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults"],"prefix":"10.1016","volume":"29","author":[{"given":"Maria Luiza","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Angela","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00e7andra Ramos","family":"Esp\u00edrito-Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Campi-Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Silveira-Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Geraldo Leite","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erna Geessien","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana Maria","family":"El\u00f3i-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.08.046_bib0005","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever","author":"Monath","year":"2008"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.046_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S0037-86822003000200012","article-title":"Febre Amarela","volume":"36","author":"Vasconcelos","year":"2003","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.046_bib0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0035-9203(96)90286-2","article-title":"The global resurgence of arboviral diseases","volume":"90","author":"Gubler","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2010.08.046_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10408360490497474","article-title":"Yellow fever: the recurring plague","volume":"41","author":"Tomori","year":"2004","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"SV","key":"10.1016\/j.vaccine.2010.08.046_bib0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0030","first-page":"1","article-title":"Insights on yellow fever immune response following natural infection and vaccination","volume":"9","author":"Silveira-Lemos","year":"2008","journal-title":"Curr Tr Immunol"},{"issue":"SV","key":"10.1016\/j.vaccine.2010.08.046_bib0035","first-page":"699","article-title":"Neutralizing and haemagglutination-inhibiting antibodies to fever 17 years after vaccination with 17D vaccine","volume":"27","author":"Groot","year":"1962","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2010.08.046_bib0040","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.046_bib0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/viro.2001.1255","article-title":"Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E","volume":"293","author":"Co","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0050","unstructured":"World Health Organization. Yellow fever vaccine. WHO position paper. Wkly. Epidemiol Rec 2003; 78:349\u201359."},{"key":"10.1016\/j.vaccine.2010.08.046_bib0055","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.046_bib0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.qco.0000178823.28585.ad","article-title":"New developments in flavivirus vaccines with special attention to yellow fever","volume":"18","author":"Pugachev","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.046_bib0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.046_bib0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03317.x","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?","volume":"148","author":"Martins","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.08.046_bib0075","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","article-title":"Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination","volume":"26","author":"Martins","year":"2008","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2010.08.046_bib0080","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.046_bib0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2008.02.007","article-title":"Detection of Th1\/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay","volume":"42","author":"Santos","year":"2008","journal-title":"Cytokine"},{"issue":"41","key":"10.1016\/j.vaccine.2010.08.046_bib0090","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2009.07.028","article-title":"TLR expression and NK cell activation after human yellow fever vaccination","volume":"27","author":"Neves","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2010.08.046_bib0095","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1086\/587844","article-title":"Immune response during adverse events after 17D-derived yellow fever vaccination in Europe","volume":"197","author":"Bae","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.046_bib0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/CVI.00369-09","article-title":"Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination","volume":"17","author":"Silva","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.046_bib0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2249.2006.03171.x","article-title":"Mixed inflammatory\/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection","volume":"146","author":"Peruhype-Magalh\u00e3es","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.046_bib0110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-3083.2008.02167.x","article-title":"Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease","volume":"68","author":"Vitelli-Avelar","year":"2008","journal-title":"Scand J Immunol"},{"issue":"SV","key":"10.1016\/j.vaccine.2010.08.046_bib0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1056\/NEJM196507222730404","article-title":"Circulating virus, interferon and antibody after vaccination with the 17-D strain of yellow-fever virus","volume":"273","author":"Wheelock","year":"1965","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.046_bib0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CDLI.2.3.302-306.1995","article-title":"Lymphocytic 2\u2032,5\u2032-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine","volume":"2","author":"Bonnevie-Nielsen","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.046_bib0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.046_bib0135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/517806","article-title":"In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination","volume":"177","author":"Hacker","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.046_bib0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1373.2000.22335.x","article-title":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis","volume":"223","author":"Herbein","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.046_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1997.0056","article-title":"Yellow fever vaccines","volume":"25","author":"Barrett","year":"1997","journal-title":"Biologicals"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.046_bib0150","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2010.08.046_bib0155","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0165","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.3945\/jn.108.092056","article-title":"Men with low vitamin A stores respond adequately to primary yellow fever and secondary tetanus toxoid vaccination","volume":"138","author":"Ahmad","year":"2008","journal-title":"J Nutr"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1988.tb00739.x","article-title":"The role of helper T cell products in mouse B cell differentiation and isotype regulation","volume":"102","author":"Coffman","year":"1988","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0175","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.140.3.705","article-title":"T cell-dependent hapten-specific and polyclonal B-cell responses require release of interleukin 5","volume":"140","author":"Rasmussen","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.iy.06.040188.002413","article-title":"Molecular regulation of B lymphocyte response","volume":"6","author":"Kishimoto","year":"1988","journal-title":"Annu Rev Immunol"},{"issue":"6 Pt 2","key":"10.1016\/j.vaccine.2010.08.046_bib0185","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0091-6749(97)70006-X","article-title":"Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: a study with allergen-specific human helper T cells","volume":"100","author":"Mori","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.08.046_bib0190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1526-4610.1998.3806465.x","article-title":"Cytokines and migraine: increase of IL-5 and IL-4 plasma levels","volume":"38","author":"Munno","year":"1998","journal-title":"Headache"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0195","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"IL-10 is a potent growth and differentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.175.3.671","article-title":"Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A","volume":"175","author":"Defrance","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0205","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/intimm\/7.8.1243","article-title":"Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4","volume":"7","author":"Rousset","year":"1995","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0210","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1172\/JCI116977","article-title":"Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein","volume":"93","author":"Levy","year":"1994","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2010.08.046_bib0215","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.046_bib0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-5793(96)00990-8","article-title":"IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes","volume":"394","author":"Wehinger","year":"1996","journal-title":"FEBS Lett"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T23:30:41Z","timestamp":1685748641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10011916"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}